C
KROS icon

Covestor’s Keros Therapeutics KROS Stock Holding History

Covestor’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
50
+45
+900% +$695 ﹤0.01% 2073
2025
Q4 		$0 Sell
5
-3,502
-100% -$61.4K ﹤0.01% 2522
2025
Q3 		$55K Sell
3,507
-5,842
-62% -$86.3K 0.03% 863
2025
Q2 		$125K Sell
9,349
-7,712
-45% -$104K 0.07% 421
2025
Q1 		$174K Buy
17,061
+15,779
+1,231% +$183K 0.12% 200
2024
Q4 		$20K Buy
1,282
+1,280
+64,000% +$66.5K 0.01% 1188
2024
Q3 		$0 Hold
2
– – ﹤0.01% 2482
2024
Q2 		$0 Hold
2
– – ﹤0.01% 2503
2024
Q1 		$0 Sell
2
-5
-71% -$296 ﹤0.01% 2508
2023
Q4 		$0 Buy
7
+4
+133% +$125 ﹤0.01% 2443
2023
Q3 		$0 Hold
3
– – ﹤0.01% 2428
2023
Q2 		$0 Hold
3
– – ﹤0.01% 2416
2023
Q1 		$0 Hold
3
– – ﹤0.01% 2323
2022
Q4 		$0 Hold
3
– – ﹤0.01% 2345
2022
Q3 		$0 Sell
3
-1
-25% -$35 ﹤0.01% 2312
2022
Q2 		$0 Sell
4
-1
-20% -$44 ﹤0.01% 2152
2022
Q1 		$0 Buy
+5
New +$257 ﹤0.01% 2300
2021
Q4 		– Hold
0
– – – 2237

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return